Skip to main content
Top
Published in: Molecular Cancer 1/2022

Open Access 01-12-2022 | Glioblastoma | Correction

Correction: A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1

Authors: Xin Xia, Xixi Li, Fanying Li, Xujia Wu, Maolei Zhang, Huangkai Zhou, Nunu Huang, Xuesong Yang, Feizhe Xiao, Dawei Liu, Lixuan Yang, Nu Zhang

Published in: Molecular Cancer | Issue 1/2022

Login to get access

Excerpt

Correction to: Mol Cancer 18, 131 (2019)
Metadata
Title
Correction: A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1
Authors
Xin Xia
Xixi Li
Fanying Li
Xujia Wu
Maolei Zhang
Huangkai Zhou
Nunu Huang
Xuesong Yang
Feizhe Xiao
Dawei Liu
Lixuan Yang
Nu Zhang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2022
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/s12943-022-01584-y

Other articles of this Issue 1/2022

Molecular Cancer 1/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine